Healthcarenews18 Apr, 2024Business
The global cancer biomarkers market is experiencing significant growth and is projected to reach USD 28.2 billion by 2026, up from USD 12.4 billion in 2021, with a compound annual growth rate (CAGR) of 17.7%. This surge in growth can be attributed to several key factors, including the rising prevalence of cancer worldwide, increasing use of cancer biomarkers in drug discovery and development, and ongoing research and development efforts in the field of cancer biomarkers. Emerging markets such as India and Japan also offer lucrative opportunities for market players operating in this space.
Mike Morse Injury Law Firm
Game No Hu Uy Tin - Danh Sach Cong Game Nohu Vip 2
Luck8
Patriot Roofer Linzy
Ku77 Casino
Ash Zi
Fun88go Org
Kubet99 Top
Miaeren1
Accurate Franchising